These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2829494)

  • 1. [Kinetics of binding of I-125-labeled heparin and its low-molecular-weight fraction CY 222 to the endothelium in vitro].
    Psuja P
    Acta Haematol Pol; 1987; 18(1-2):35-41. PubMed ID: 2829494
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of antithrombin III on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro].
    Psuja P
    Acta Haematol Pol; 1988; 19(3-4):143-9. PubMed ID: 2855291
    [No Abstract]   [Full Text] [Related]  

  • 3. [Binding of technetium 99m-labeled heparin and its low molecular weight fractions CY 216 and CY 222 to human endothelium in vitro].
    Psuja P
    Pol Tyg Lek; 1987 Jul; 42(30):903-6. PubMed ID: 2823236
    [No Abstract]   [Full Text] [Related]  

  • 4. Affinity of binding of radiolabeled (125I) heparin and low molecular weight heparin fraction CY 222 to endothelium in culture.
    Psuja P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):429-36. PubMed ID: 2444518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture.
    Bârzu T; Molho P; Tobelem G; Petitou M; Caen JP
    Nouv Rev Fr Hematol (1978); 1984; 26(4):243-7. PubMed ID: 6473094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and endocytosis of heparin by human endothelial cells in culture.
    Bârzu T; Molho P; Tobelem G; Petitou M; Caen J
    Biochim Biophys Acta; 1985 May; 845(2):196-203. PubMed ID: 3995089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of unfractionated heparin and low molecular weight heparin to thrombin-activated human endothelial cells.
    Young E; Venner T; Ribau J; Shaughnessy S; Hirsh J; Podor TJ
    Thromb Res; 1999 Dec; 96(5):373-81. PubMed ID: 10605952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
    Khorana AA; Sahni A; Altland OD; Francis CW
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of low molecular weight heparin (Tinzaparin sodium) to bovine endothelial cells in vitro.
    Larnkjaer A; Ostergaard PB; Flodgaard HJ
    Thromb Res; 1994 Jul; 75(2):185-94. PubMed ID: 7974392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.
    Baruch D; Ajzenberg N; Denis C; Legendre P; Lormeau JC; Meyer D
    Thromb Haemost; 1994 Jan; 71(1):141-6. PubMed ID: 8165633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding, internalization and degradation of heparin and heparin fragments by cultured endothelial cells.
    Vannucchi S; Pasquali F; Porciatti F; Chiarugi V; Magnelli L; Bianchini P
    Thromb Res; 1988 Feb; 49(4):373-83. PubMed ID: 2837834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin.
    Young E; Wells P; Holloway S; Weitz J; Hirsh J
    Thromb Haemost; 1994 Mar; 71(3):300-4. PubMed ID: 8029793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of heparan sulfate and its fractions with endothelial cells in culture.
    Tiozzo R; Cingi MR; Croce MA
    Int J Tissue React; 1993; 15(4):163-8. PubMed ID: 8188456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific heparin fractions suppress endothelin-1 production in cultured human umbilical vein endothelial cells.
    Reantragoon S; Arrigo LM; Seoud MM; Dweck HS; Rosenfeld L
    Arch Biochem Biophys; 1994 Nov; 314(2):315-22. PubMed ID: 7979371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
    Yamazaki Y; Tokunaga Y; Takani K; Morita T
    Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effect of polysaccharide sulfate on human umbilical vein endothelial cell (HUVEC) injury in vitro].
    Hu MW; Zhou XB; Zhang LH; Xu HY
    Yao Xue Xue Bao; 1995; 30(9):641-5. PubMed ID: 8701737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of endothelin-1 production in cultured human umbilical vein endothelial cells by heparin fractions separated by strong anion exchange chromatography.
    Reantragoon S; Arrigo LM; Dweck HS; Rosenfeld L
    Arch Biochem Biophys; 1996 Mar; 327(2):234-8. PubMed ID: 8619608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview: from heparin to low molecular weight heparin: beyond anticoagulation.
    Mousa SA; Fareed J
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1077-80. PubMed ID: 11892916
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitro.
    Brack MJ; More RS; Spring E; Gershlick AH
    Thromb Res; 1993 May; 70(4):329-35. PubMed ID: 8332962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin interactions with cultured human vascular endothelial and smooth muscle cells: incidence on vascular smooth muscle cell proliferation.
    Herbert JM; Maffrand JP
    J Cell Physiol; 1989 Feb; 138(2):424-32. PubMed ID: 2918044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.